We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$13.4B
AUM Growth
+$11.7M
Cap. Flow
-$909M
Cap. Flow %
-6.79%
Top 10 Hldgs %
8.68%
Holding
1,051
New
69
Increased
286
Reduced
463
Closed
85

Top Buys

Rank Stock Value
1
HRB icon
H&R Block
HRB
+$34.1M
2
NEWT icon
NewtekOne
NEWT
+$25.9M
3
BVS icon
Bioventus
BVS
+$25.4M
4
TGNA
TEGNA Inc
TGNA
+$24.7M
5
LPX icon
Louisiana-Pacific
LPX
+$24.6M

Sector Composition

Rank Sector Weight
1 Industrials 25.47%
2 Technology 20.75%
3 Financials 14.3%
4 Consumer Discretionary 14.11%
5 Materials 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVGI icon
401
Commercial Vehicle Group
CVGI
$147M
$9.83M 0.07%
1,219,983
+117,432
+11% +$1.06M
NVGS icon
402
Navigator Holdings
NVGS
$1.37B
$9.79M 0.07%
1,103,188
-19,300
-2% -$169K
NVEE
403
DELISTED
NV5 Global
NVEE
$9.65M 0.07%
279,480
-920
-0.3% -$26.5K
IHC
404
DELISTED
Independence Holding Company
IHC
$9.64M 0.07%
170,023
OCDX
405
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$9.61M 0.07%
449,168
-253,700
-36% -$5M
AXTI icon
406
AXT Inc
AXTI
$3.07B
$9.57M 0.07%
1,086,100
+181,500
+20% +$1.53M
QTRX icon
407
Quanterix
QTRX
$166M
$9.47M 0.07%
223,448
-70,631
-24% -$3.3M
SEM
408
DELISTED
Select Medical
SEM
$9.43M 0.07%
595,431
-78,835
-12% -$1.35M
SNEX icon
409
StoneX
SNEX
$9.39B
$9.35M 0.07%
772,907
+47,081
+6% +$617K
HRMY icon
410
Harmony Biosciences
HRMY
$2.08B
$9.34M 0.07%
219,084
-10,306
-4% -$411K
AMBA icon
411
Ambarella
AMBA
$3.25B
$9.23M 0.07%
45,500
TROX icon
412
Tronox
TROX
$999M
$9.22M 0.07%
383,820
-36,600
-9% -$876K
ALK icon
413
Alaska Air
ALK
$5.27B
$9.21M 0.07%
176,836
+18,000
+11% +$975K
MX icon
414
Magnachip Semiconductor
MX
$116M
$9.2M 0.07%
438,661
PI icon
415
Impinj
PI
$4.51B
$9.18M 0.07%
103,500
+42,500
+70% +$3.08M
ARAY icon
416
Accuray
ARAY
$34M
$9.17M 0.07%
1,922,865
+163,185
+9% +$787K
MAN icon
417
ManpowerGroup
MAN
$2.41B
$9.16M 0.07%
94,121
+3,450
+4% +$346K
GTX icon
418
Garrett Motion
GTX
$5.78B
$9.15M 0.07%
1,139,504
+634,073
+125% +$4.67M
GIC icon
419
Global Industrial
GIC
$1.35B
$9.1M 0.07%
222,469
-155,085
-41% -$6.36M
AHRT
420
AH Realty Trust
AHRT
$536M
$9.09M 0.07%
597,135
-439,053
-42% -$6.32M
SAIA icon
421
Saia
SAIA
$9.33B
$9.04M 0.07%
26,811
-79,381
-75% -$24.6M
HTB
422
HomeTrust Bancshares
HTB
$860M
$9.02M 0.07%
291,226
-42,407
-13% -$1.29M
TRC icon
423
Tejon Ranch
TRC
$460M
$8.95M 0.07%
468,812
-263,612
-36% -$4.99M
CENTA icon
424
Central Garden & Pet Co Class A
CENTA
$2.38B
$8.9M 0.07%
232,380
-61,875
-21% -$2.29M
LTHM
425
DELISTED
Livent Corporation
LTHM
$8.88M 0.07%
364,213
-514,700
-59% -$14M

Similar funds

Royce & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Royce & Associates held 1,051 positions worth $13.4B, up 0.09% from $13.4B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Royce & Associates withdrew a net $909M in Q4 2021, closing 85 positions and reducing 463 holdings. Its most notable exit was Meredith Corporation, an estimated $52.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in NewtekOne worth $24.4M.

  • Royce & Associates's largest Q4 2021 buy was NewtekOne: 884,357 shares worth $24.4M.
  • Royce & Associates added most to H&R Block in Q4 2021, an estimated $34.1M increase.
  • Royce & Associates's biggest Q4 2021 reduction was Upland Software, cutting an estimated $53.8M.
  • Royce & Associates fully exited Meredith Corporation in Q4 2021, selling an estimated $52.5M.
  • Royce & Associates's ten largest holdings make up 8.7% of its $13.4B portfolio in Q4 2021.
  • Royce & Associates opened 69 new positions and closed 85 in Q4 2021.
  • Royce & Associates's portfolio value rose 0.09% quarter-over-quarter to $13.4B.

Based on Royce & Associates's 13F filing for Q4 2021, filed 7 Feb 2022.